CC BY-NC-ND 4.0 · Aorta (Stamford) 2023; 11(01): 010-019
DOI: 10.1055/a-2000-7812
Original Research Article

Ascending Aortic Aneurysms <4.5 cm for Nonsyndromic Adults: Very Slow Growth and Low Risk

1   TriHealth Heart Institute, Cardiothoracic Surgery, Bethesda North Hospital, Cincinnati, Ohio
,
Tiffany Hanlon
1   TriHealth Heart Institute, Cardiothoracic Surgery, Bethesda North Hospital, Cincinnati, Ohio
,
Katherine Vorpe
2   TriHealth Clinical Training and Testing Center, Bethesda North Hospital, Cincinnati, Ohio
› Author Affiliations
Funding This work was funded by Educational Grant from the Bethesda Foundation.

Abstract

Background Current practice guidelines for patients with thoracic aortic aneurysms (TAAs) recommend 6 to 12-month intervals for surveillance imaging based on growth estimates of 0.10 to 0.42 cm/y gleaned from limited studies which included patients with thoracoabdominal aneurysms, known acute or chronic aortic dissection, and other syndromic and nonsyndromic high-risk conditions (TAA-HRC) associated with high-risk for adverse aortic events and death. Our objective was to determine TAA growth and event-free survival rates for patients with aortic root or midascending diameters <5.0 cm, and without thoracoabdominal aneurysms, acute or chronic aortic dissection or higher risk syndromic or nonsyndromic conditions (TAA-NoHRC).

Methods A retrospective review of patient records and imaging studies were done. Aortic diameter measurements were all performed by the lead author.

Results For 197 TAA-NoHRC found incidentally during chest imaging, with 616 chest imaging studies over 868 patient-years, the mean aortic root and midascending aortic growth rates were 0.018 and 0.022 cm/y, respectively. The growth rate was significantly lower for aneurysms initially measured at <4.5 cm versus ≥ 4.5 cm at both the aortic root (0.011 vs. 0.068 cm/y) and midascending aorta (0.013 vs. 0.043 cm/y). Survival free from adverse aortic events (dissection, rupture, and surgery) or death at 5 years was 99.5%.

Conclusion Adult TAA-NoHRC patients with initial aortic root and/or ascending aortic diameters <5.0 cm, and particularly <4.5 cm, have very low aortic growth, and adverse event rates which may permit longer intervals between surveillance imaging, up to 3 to 5 years, after initial (6–12 months) stability is documented.



Publication History

Received: 25 May 2022

Accepted: 09 December 2022

Accepted Manuscript online:
20 December 2022

Article published online:
27 February 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Hiratzka LF, Bakris GL, Beckman JA. et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121 (13) e266-e369
  • 2 Erbel R, Aboyans V, Boileau C. et al; ESC Committee for Practice Guidelines, The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. Eur Heart J 2014; 35 (41) 2873-2926
  • 3 JCS Joint Working Group. Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection (JCS 2011): digest version. Circ J 2013; 77 (03) 789-828
  • 4 Cambria RA, Gloviczki P, Stanson AW. et al. Outcome and expansion rate of 57 thoracoabdominal aortic aneurysms managed nonoperatively. Am J Surg 1995; 170 (02) 213-217
  • 5 Coady MA, Rizzo JA, Hammond GL. et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms?. J Thorac Cardiovasc Surg 1997; 113 (03) 476-491 , discussion 489–491
  • 6 Davies RR, Goldstein LJ, Coady MA. et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002; 73 (01) 17-27
  • 7 Gagné-Loranger M, Dumont É, Voisine P, Mohammadi S, Dagenais F. Natural history of 40-50 mm root/ascending aortic aneurysms in the current era of dedicated thoracic aortic clinics. Eur J Cardiothorac Surg 2016; 50 (03) 562-566
  • 8 Geisbüsch S, Stefanovic A, Schray D. et al. A prospective study of growth and rupture risk of small-to-moderate size ascending aortic aneurysms. J Thorac Cardiovasc Surg 2014; 147 (01) 68-74
  • 9 McLarty AJ, Bishawi M, Yelika SB, Shroyer AL, Romeiser J. Surveillance of moderate-size aneurysms of the thoracic aorta. J Cardiothorac Surg 2015; 10: 17
  • 10 Bathen T, Krohg-Sørensen K, Lidal IB. Multidisciplinary aortopathy clinics: a systematic scoping review of the literature and evaluation of patient experiences from a newly started clinic in Norway. Am J Med Genet A 2020; 182 (11) 2552-2569
  • 11 Singh S, Nautiyal A. Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis. Am J Med 2017; 130 (12) 1449-1457
  • 12 Frankel WC, Trautner BW, Spiegelman A, Grigoryan L, LeMaire SA. Patients at risk for aortic rupture often exposed to fluoroquinolones during hospitalization. Antimicrob Agents Chemother 2019; 63 (02) e01712-e01718
  • 13 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71 (19) e127-e248
  • 14 Zafar MA, Li Y, Rizzo JA. et al. Height alone, rather than body surface area, suffices for risk estimation in ascending aortic aneurysm. J Thorac Cardiovasc Surg 2018; 155 (05) 1938-1950
  • 15 Oladokun D, Patterson BO, Sobocinski J. et al. Systematic review of the growth rates and influencing factors in thoracic aortic aneurysms. Eur J Vasc Endovasc Surg 2016; 51 (05) 674-681
  • 16 Kim JB, Spotnitz M, Lindsay ME, MacGillivray TE, Isselbacher EM, Sundt III TM. Risk of aortic dissection in the moderately dilated ascending aorta. J Am Coll Cardiol 2016; 68 (11) 1209-1219
  • 17 Treskes K, Bos SA, Beenen LFM. et al; REACT-2 study group. High rates of clinically relevant incidental findings by total-body CT scanning in trauma patients; results of the REACT-2 trial. Eur Radiol 2017; 27 (06) 2451-2462
  • 18 Itani Y, Watanabe S, Masuda Y. et al. Measurement of aortic diameters and detection of asymptomatic aortic aneurysms in a mass screening program using a mobile helical computed tomography unit. Heart Vessels 2002; 16 (02) 42-45
  • 19 Krueger M, Cronin P, Sayyouh M, Kelly AM. Significant incidental cardiac disease on thoracic CT: what the general radiologist needs to know. Insights Imaging 2019; 10 (01) 10-26
  • 20 Fazel R, Krumholz HM, Wang Y. et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361 (09) 849-857
  • 21 Niiranen TJ, Mäki J, Puukka P, Karanko H, Jula AM. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension 2014; 64 (02) 281-286